In this review, we summarize the pieces of evidence showing that PACAP and VIP administration help to preserve cognitive function in different preclinical models of Alzheimer’s disease (AD), Parkinson’s disease (PD) and Huntington’s disease (HD). The gene discussed is ADCYAP1; the disease is Huntington disease.